Robin Joyce - Concepedia

Author

Robin Joyce

Beth Israel Deaconess Medical Center ORCID

Also Known As

R Joyce, R M Joyce, R. Joyce, R.M. Joyce, Rachel Joyce, Robin Joyce, Robin M Joyce, Robin M. Joyce, Robin Marie Joyce, Robin M. Joyce

196

Publications

7.7K

Citations

H-Index

Concepts

All Affiliations

Beth Israel Deaconess Medical Center Dana-Farber Cancer Institute Harvard University Massachusetts General Hospital Brigham and Women's Hospital

About

Robin Joyce is an author at Beth Israel Deaconess Medical Center specializing in medicine, immunology, and immunotherapy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	27	1.3K
2	Health Sciences	8	8	301
3	Public Health	2	2	41
4	Allergy	1	1	282
5	Biostatistics	1	1	13

Robin Joyce

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
Randomized Controlled Trial of Yttrium-90–Labeled Ibritumomab Tiuxetan Radioimmunotherapy Versus Rituximab Immunotherapy for Patients With Relapsed or Refractory Low-Grade, Follicular, or Transformed B-Cell Non-Hodgkin’s Lymphoma Thomas E. Witzig, Leo I. Gordon, Fernando Cabanillas, Journal of Clinical Oncology	2002	1.2K
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease John Koreth, Ken‐ichi Matsuoka, Haesook T. Kim, New England Journal of Medicine	2011	1.1K
Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma Paul G. Richardson, Edie Weller, Sagar Lonial, Blood	2010	855
PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine Jacalyn Rosenblatt, Brett Glotzbecker, Heidi Mills, Journal of Immunotherapy Active MyelomaPd-1 BlockadeImmunologyImmune RegulationCd4 T Cell Responses	2011	282
Bendamustine is effective therapy in patients with rituximab‐refractory, indolent B‐cell non‐Hodgkin lymphoma Brad S. Kahl, Nancy L. Bartlett, John P. Leonard, Cancer	2009	245
Vaccination with dendritic cell/tumor fusion cells results in cellular and humoral antitumor immune responses in patients with multiple myeloma Jacalyn Rosenblatt, Baldev Vasir, Lynne Uhl, Blood	2010	225
Vaccination with Dendritic Cell/Tumor Fusions following Autologous Stem Cell Transplant Induces Immunologic and Clinical Responses in Multiple Myeloma Patients Jacalyn Rosenblatt, Irit Avivi, Baldev Vasir, Clinical Cancer Research	2013	208
HIGH DOSE BICALUTAMIDE FOR ANDROGEN INDEPENDENT PROSTATE CANCER: EFFECT OF PRIOR HORMONAL THERAPY Robin Joyce, Mary Anne Fenton, P Rode, The Journal of Urology	1998	206
Multicenter Clinical Trial of Bortezomib in Relapsed/Refractory Waldenstrom's Macroglobulinemia: Results of WMCTG Trial 03-248 Steven P. Treon, Zachary R. Hunter, Jeffrey Matous, Clinical Cancer Research	2007	189
MUC1-mediated induction of myeloid-derived suppressor cells in patients with acute myeloid leukemia Athalia R. Pyzer, Dina Stroopinsky, Hasan Rajabi, Blood	2017	189

Page 1